# MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy

> **NCT06197126** · — · NOT_YET_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Cervical Cancer
- Radiotherapy
- Prognostic Model
- MRI

## Interventions

- **RADIATION:** Treatment mainly composed of external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT) .

## Key facts

- **NCT ID:** NCT06197126
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197126, "MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06197126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*